Mettler-Toledo International, Inc. MTD

1,511.64 (7.51) (0.49%) as of 25 Sep
Market cap
$30.4B
P/E
33.9×
Indexes indicate stock being part of an index

Mettler-Toledo International, Inc. (MTD) P/S ratio

As of 25 September 2026, Mettler-Toledo International, Inc. (MTD) trades at a P/S ratio of 7.4×. Over the past ten years it has ranged from 3.2× (September 2015) to 10.8× (December 2021); the current reading is higher than 71% of that period. That is above the Diagnostics & Research industry median of 4.9× and above the Healthcare sector median of 3.8×.

P/S ratio, daily

Annual

Period P/S ratio Change
FY2025 7.1× 6.42%
FY2024 6.7× (4.23%)
FY2023 7.0× (16.52%)
FY2022 8.4× (20.55%)
FY2021 10.6× 19.68%
FY2020 8.8× 36.20%
FY2019 6.5× 33.34%
FY2018 4.9× (17.77%)
FY2017 5.9× 32.31%
FY2016 4.5× 13.94%

Quarterly

Period P/S ratio Change
Jun 2026 6.2× (0.60%)
Mar 2026 6.3× (12.34%)
Dec 2025 7.1× 11.72%
Sep 2025 6.4× 1.64%
42 more quarters

Against its own ten years

Low 3.2× High 10.8×
Ten-year median 6.4×
Current reading's percentile 71

P/S ratio against peers

Company P/S ratio
LH Labcorp Holdings Inc. compare 1.8×
DGX Quest Diagnostics Incorporated compare 2.3×
IQV IQVIA Holdings Inc. compare 2.6×
A Agilent Technologies, Inc. compare 6.6×
MTD Mettler-Toledo International, Inc. 7.4×
IDXX IDEXX Laboratories, Inc. compare 9.0×
ILMN Illumina, Inc. compare 9.2×
WAT Waters Corporation compare 9.2×
GH Guardant Health, Inc. compare 19.9×
Diagnostics & Research industry median 4.9×
Healthcare sector median 3.8×
Market median 2.0×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on MTD